Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 709

1.

Correction to: Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.

Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard AM, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R, Hamdy NAT, Collins MT.

Orphanet J Rare Dis. 2019 Nov 21;14(1):267. doi: 10.1186/s13023-019-1255-6.

2.

A naturalistic paradigm simulating gaze-based social interactions for the investigation of social agency.

Brandi ML, Kaifel D, Lahnakoski JM, Schilbach L.

Behav Res Methods. 2019 Nov 11. doi: 10.3758/s13428-019-01299-x. [Epub ahead of print]

PMID:
31712998
3.

A look at actions: Direct gaze modulates functional connectivity of the right TPJ with an action control network.

Zillekens IC, Schliephake LM, Brandi ML, Schilbach L.

Soc Cogn Affect Neurosci. 2019 Oct 8. pii: nsz071. doi: 10.1093/scan/nsz071. [Epub ahead of print]

PMID:
31593216
4.

Human Circulating miRNAs Real-time qRT-PCR-based Analysis: An Overview of Endogenous Reference Genes Used for Data Normalization.

Donati S, Ciuffi S, Brandi ML.

Int J Mol Sci. 2019 Sep 5;20(18). pii: E4353. doi: 10.3390/ijms20184353. Review.

5.

Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone.

Cronin O, Forsyth L, Goodman K, Lewis SC, Keerie C, Walker A, Porteous M, Cetnarskyj R, Ranganath LR, Selby PL, Hampson G, Chandra R, Ho S, Tobias JH, Young-Min S, McKenna MJ, Crowley RK, Fraser WD, Gennari L, Nuti R, Brandi ML, Del Pino-Montes J, Devogelaer JP, Durnez A, Isaia G, Di Stefano M, Guañabens N, Blanch J, Seibel MJ, Walsh JP, Kotowicz MA, Nicholson GC, Duncan EL, Major G, Horne A, Gilchrist NL, Boers M, Murray GD, Charnock K, Wilkinson D, Russell RGG, Ralston SH.

BMJ Open. 2019 Sep 4;9(9):e030689. doi: 10.1136/bmjopen-2019-030689.

6.

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.

Lorentzon M, Branco J, Brandi ML, Bruyère O, Chapurlat R, Cooper C, Cortet B, Diez-Perez A, Ferrari S, Gasparik A, Herrmann M, Jorgensen NR, Kanis J, Kaufman JM, Laslop A, Locquet M, Matijevic R, McCloskey E, Minisola S, Pikner R, Reginster JY, Rizzoli R, Szulc P, Vlaskovska M, Cavalier E.

Adv Ther. 2019 Oct;36(10):2811-2824. doi: 10.1007/s12325-019-01063-9. Epub 2019 Aug 22.

7.

Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO).

Biver E, Berenbaum F, Valdes AM, Araujo de Carvalho I, Bindels LB, Brandi ML, Calder PC, Castronovo V, Cavalier E, Cherubini A, Cooper C, Dennison E, Franceschi C, Fuggle N, Laslop A, Miossec P, Thomas T, Tuzun S, Veronese N, Vlaskovska M, Reginster JY, Rizzoli R.

Ageing Res Rev. 2019 Nov;55:100946. doi: 10.1016/j.arr.2019.100946. Epub 2019 Aug 19. Review.

8.

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Diez-Perez A, Brandi ML, Al-Daghri N, Branco JC, Bruyère O, Cavalli L, Cooper C, Cortet B, Dawson-Hughes B, Dimai HP, Gonnelli S, Hadji P, Halbout P, Kaufman JM, Kurth A, Locquet M, Maggi S, Matijevic R, Reginster JY, Rizzoli R, Thierry T.

Aging Clin Exp Res. 2019 Oct;31(10):1375-1389. doi: 10.1007/s40520-019-01294-4. Epub 2019 Aug 17.

9.

Evidence of a possible therapeutic role of vitamin D in a cohort of adult Caucasian vitiligo patients.

Colucci R, Conti R, Dragoni F, Cammi A, Cianferotti L, Brandi ML, Moretti S.

Int J Vitam Nutr Res. 2019 Aug 15:1-5. doi: 10.1024/0300-9831/a000605. [Epub ahead of print]

PMID:
31414974
10.

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF).

Hiligsmann M, Cornelissen D, Vrijens B, Abrahamsen B, Al-Daghri N, Biver E, Brandi ML, Bruyère O, Burlet N, Cooper C, Cortet B, Dennison E, Diez-Perez A, Gasparik A, Grosso A, Hadji P, Halbout P, Kanis JA, Kaufman JM, Laslop A, Maggi S, Rizzoli R, Thomas T, Tuzun S, Vlaskovska M, Reginster JY.

Osteoporos Int. 2019 Nov;30(11):2155-2165. doi: 10.1007/s00198-019-05104-5. Epub 2019 Aug 7.

11.

Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.

Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard AM, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R, Hamdy NAT, Collins MT.

Orphanet J Rare Dis. 2019 Jun 13;14(1):139. doi: 10.1186/s13023-019-1102-9. Erratum in: Orphanet J Rare Dis. 2019 Nov 21;14(1):267.

12.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.

Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Zhang L, Theodore-Oklota C, Mealiffe M, San Martin J, Insogna K.

Calcif Tissue Int. 2019 Sep;105(3):271-284. doi: 10.1007/s00223-019-00568-3. Epub 2019 Jun 4.

PMID:
31165191
13.

X-linked hypophosphatemic rickets: an Italian experts' opinion survey.

Emma F, Cappa M, Antoniazzi F, Bianchi ML, Chiodini I, Eller Vainicher C, Di Iorgi N, Maghnie M, Cassio A, Balsamo A, Baronio F, de Sanctis L, Tessaris D, Baroncelli GI, Mora S, Brandi ML, Weber G, D'Ausilio A, Lanati EP.

Ital J Pediatr. 2019 May 31;45(1):67. doi: 10.1186/s13052-019-0654-6.

14.

Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors.

Marcucci G, Beltrami G, Tamburini A, Body JJ, Confavreux CB, Hadji P, Holzer G, Kendler D, Napoli N, Pierroz DD, Rizzoli R, Brandi ML.

Ann Oncol. 2019 May 21. pii: mdz120. doi: 10.1093/annonc/mdz120. [Epub ahead of print]

PMID:
31111878
15.

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.

Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A.

Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. Review.

PMID:
31068690
16.

Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1.

Domazetovic V, Marcucci G, Pierucci F, Bruno G, Di Cesare Mannelli L, Ghelardini C, Brandi ML, Iantomasi T, Meacci E, Vincenzini MT.

FEBS Open Bio. 2019 Jun;9(6):1082-1096. doi: 10.1002/2211-5463.12634. Epub 2019 Apr 20.

17.

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

de Wit M, Cooper C, Tugwell P, Bere N, Kirwan J, Conaghan PG, Roberts C, Aujoulat I, Al-Daghri N, Araujo de Carvalho I, Barker M, Bedlington N, Brandi ML, Bruyère O, Burlet N, Halbout P, Hiligsmann M, Jiwa F, Kanis JA, Laslop A, Lawrence W, Pinto D, Prieto Yerro C, Rabenda V, Rizzoli R, Scholte-Voshaar M, Vlaskovska M, Reginster JY.

Aging Clin Exp Res. 2019 Jul;31(7):905-915. doi: 10.1007/s40520-019-01193-8. Epub 2019 Apr 16. Review.

18.

Muscle endocrinology and its relation with nutrition.

Romagnoli C, Pampaloni B, Brandi ML.

Aging Clin Exp Res. 2019 Jun;31(6):783-792. doi: 10.1007/s40520-019-01188-5. Epub 2019 Apr 11. Review.

PMID:
30977083
19.

Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.

Ciuffi S, Cianferotti L, Nesi G, Luzi E, Marini F, Giusti F, Zonefrati R, Gronchi G, Perigli G, Brandi ML.

Endocr J. 2019 Apr 25;66(4):319-327. doi: 10.1507/endocrj.EJ18-0387. Epub 2019 Feb 22.

20.

The authors reply: Letter on: "Pitfalls in the measurement of muscle mass: a need for a reference standard" by Clark et al.

Buckinx F, Landi F, Cesari M, Fieding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S, Bauer J, Bautmans I, Brandi ML, Bruyère O, Cederholm T, Cerreta F, Cherubini A, Cooper C, Cruz-Jentoft A, McCloskey E, Dawson-Hughes B, Kaufman JM, Laslop A, Petermans J, Reginster JY, Rizzoli R, Robinson S, Rolland Y, Rueda R, Vellas B, Kanis JA.

J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1272-1274. doi: 10.1002/jcsm.12387.

21.

Clinical presentation and management of hypoparathyroidism.

Marcucci G, Cianferotti L, Brandi ML.

Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):927-939. doi: 10.1016/j.beem.2018.09.007. Epub 2018 Sep 28. Review.

PMID:
30665553
22.

Causes and pathophysiology of hypoparathyroidism.

Cianferotti L, Marcucci G, Brandi ML.

Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):909-925. doi: 10.1016/j.beem.2018.07.001. Epub 2018 Jul 29. Review.

PMID:
30665552
23.

The biomolecular interactions between endothelium and bone cells: an overview.

Carulli C, Innocenti M, Lazzarini F, Villano M, Pasta G, Brandi ML, Innocenti M.

J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6 Suppl. 1):173-179. Review.

PMID:
30644299
24.

Conventional Treatment of Hypoparathyroidism.

Marcucci G, Brandi ML.

Front Horm Res. 2019;51:160-164. doi: 10.1159/000491046. Epub 2018 Nov 19. Review.

PMID:
30641530
25.

A New Era for Chronic Management of Hypoparathyroidism: Parathyroid Hormone Peptides.

Marcucci G, Brandi ML.

Front Horm Res. 2019;51:165-171. doi: 10.1159/000491047. Epub 2018 Nov 19. Review.

PMID:
30641529
26.

Familial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism.

Vannucci L, Brandi ML.

Front Horm Res. 2019;51:52-62. doi: 10.1159/000491038. Epub 2018 Nov 19. Review.

PMID:
30641521
27.

Clinical Presentation of Hypoparathyroidism.

Giusti F, Brandi ML.

Front Horm Res. 2019;51:139-146. doi: 10.1159/000491044. Epub 2018 Nov 19. Review.

PMID:
30641520
28.

Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters.

Vannucci L, Fossi C, Quattrini S, Guasti L, Pampaloni B, Gronchi G, Giusti F, Romagnoli C, Cianferotti L, Marcucci G, Brandi ML.

Nutrients. 2018 Dec 5;10(12). pii: E1930. doi: 10.3390/nu10121930. Review.

29.

Standards of Care for Hypoparathyroidism in Adults.

Khan AA, Koch C, Van Uum SHM, Baillargeon JP, Bollerslev J, Brandi ML, Marcocci C, Rejnmark L, Rizzoli R, Shrayyef MZ, Thakker RV, Yildiz BO, Clarke B.

Eur J Endocrinol. 2018 Dec 1. pii: EJE-18-0609.R1. doi: 10.1530/EJE-18-0609. [Epub ahead of print]

30.

Increased functional coupling of the left amygdala and medial prefrontal cortex during the perception of communicative point-light stimuli.

Zillekens IC, Brandi ML, Lahnakoski JM, Koul A, Manera V, Becchio C, Schilbach L.

Soc Cogn Affect Neurosci. 2019 Jan 4;14(1):97-107. doi: 10.1093/scan/nsy105.

31.

MANAGEMENT OF ENDOCRINE DISEASE: Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management.

Khan AA, Clarke B, Rejnmark L, Brandi ML.

Eur J Endocrinol. 2019 Feb 1;180(2):R37-R44. doi: 10.1530/EJE-18-0541. Review.

PMID:
30444723
32.

The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases.

Hannan FM, Kallay E, Chang W, Brandi ML, Thakker RV.

Nat Rev Endocrinol. 2018 Dec;15(1):33-51. doi: 10.1038/s41574-018-0115-0. Review.

33.

Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.

Marini F, Giusti F, Brandi ML.

Orphanet J Rare Dis. 2018 Nov 14;13(1):205. doi: 10.1186/s13023-018-0938-8.

34.

Conventional Treatment of Hypoparathyroidism.

Babey M, Brandi ML, Shoback D.

Endocrinol Metab Clin North Am. 2018 Dec;47(4):889-900. doi: 10.1016/j.ecl.2018.07.012. Review.

PMID:
30390820
35.

Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.

Habibullah M, Porter JA, Kluger N, Ranki A, Krohn KJE, Brandi ML, Brown EM, Weetman AP, Kemp EH.

J Immunol. 2018 Dec 1;201(11):3175-3183. doi: 10.4049/jimmunol.1701527. Epub 2018 Oct 31.

36.

When Parathyroidectomy Should Be Indicated or Postponed in Adolescents With MEN1-Related Primary Hyperparathyroidism.

Marini F, Giusti F, Tonelli F, Brandi ML.

Front Endocrinol (Lausanne). 2018 Oct 5;9:597. doi: 10.3389/fendo.2018.00597. eCollection 2018.

37.

Total and Subtotal Parathyroidectomy in Young Patients With Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism: Potential Post-surgical Benefits and Complications.

Tonelli F, Marini F, Giusti F, Brandi ML.

Front Endocrinol (Lausanne). 2018 Sep 24;9:558. doi: 10.3389/fendo.2018.00558. eCollection 2018.

38.

Cow's Milk Consumption and Health: A Health Professional's Guide.

Marangoni F, Pellegrino L, Verduci E, Ghiselli A, Bernabei R, Calvani R, Cetin I, Giampietro M, Perticone F, Piretta L, Giacco R, La Vecchia C, Brandi ML, Ballardini D, Banderali G, Bellentani S, Canzone G, Cricelli C, Faggiano P, Ferrara N, Flachi E, Gonnelli S, Macca C, Magni P, Marelli G, Marrocco W, Miniello VL, Origo C, Pietrantonio F, Silvestri P, Stella R, Strazzullo P, Troiano E, Poli A.

J Am Coll Nutr. 2019 Mar-Apr;38(3):197-208. doi: 10.1080/07315724.2018.1491016. Epub 2018 Sep 24.

PMID:
30247998
39.

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies.

Kendler DL, Chines A, Brandi ML, Papapoulos S, Lewiecki EM, Reginster JY, Muñoz Torres M, Wang A, Bone HG.

Osteoporos Int. 2019 Jan;30(1):71-78. doi: 10.1007/s00198-018-4687-2. Epub 2018 Sep 22.

40.

Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck.

Di Paola M, Gatti D, Viapiana O, Cianferotti L, Cavalli L, Caffarelli C, Conversano F, Quarta E, Pisani P, Girasole G, Giusti A, Manfredini M, Arioli G, Matucci-Cerinic M, Bianchi G, Nuti R, Gonnelli S, Brandi ML, Muratore M, Rossini M.

Osteoporos Int. 2019 Feb;30(2):391-402. doi: 10.1007/s00198-018-4686-3. Epub 2018 Sep 4.

PMID:
30178159
41.

Bone management in hematologic stem cell transplant recipients.

Kendler DL, Body JJ, Brandi ML, Broady R, Cannata-Andia J, Cannata-Ortiz MJ, El Maghraoui A, Guglielmi G, Hadji P, Pierroz DD, de Villiers TJ, Rizzoli R, Ebeling PR; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer and Bone Disease.

Osteoporos Int. 2018 Dec;29(12):2597-2610. doi: 10.1007/s00198-018-4669-4. Epub 2018 Sep 3. Review.

PMID:
30178158
42.

Functional outcomes and mortality in geriatric and fragility hip fractures-results of an integrated, multidisciplinary model experienced by the "Florence hip fracture unit".

Civinini R, Paoli T, Cianferotti L, Cartei A, Boccaccini A, Peris A, Brandi ML, Rostagno C, Innocenti M.

Int Orthop. 2019 Jan;43(1):187-192. doi: 10.1007/s00264-018-4132-3. Epub 2018 Aug 29.

PMID:
30159804
43.

The Authors reply: "Dual energy X-ray absorptiometry: gold standard for muscle mass?" by Scafoglieri et al.

Buckinx F, Landi F, Cesari M, Fieding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S, Bauer J, Bautmans I, Brandi ML, Bruyère O, Cederholm T, Cerreta F, Cherubini A, Cooper C, Cruz-Jentoft A, McCloskey E, Dawson-Hughes B, Kaufman JM, Laslop A, Petermans J, Reginster JY, Rizzoli R, Robinson S, Rolland Y, Rueda R, Vellas B, Kanis JA.

J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):788-790. doi: 10.1002/jcsm.12329. Epub 2018 Aug 14. No abstract available.

44.

Surgical management of chordoma: A systematic review.

Denaro L, Berton A, Ciuffreda M, Loppini M, Candela V, Brandi ML, Longo UG.

J Spinal Cord Med. 2018 Jul 26:1-16. doi: 10.1080/10790268.2018.1483593. [Epub ahead of print]

PMID:
30048230
45.

Correction to: Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.

Marini F, Giusti F, Fossi C, Cioppi F, Cianferotti L, Masi L, Boaretto F, Zovato S, Cetani F, Colao A, Davì MV, Faggiano A, Fanciulli G, Ferolla P, Ferone D, Loli P, Mantero F, Marcocci C, Opocher G, Beck-Peccoz P, Persani L, Scillitani A, Guizzardi F, Spada A, Tomassetti P, Tonelli F, Brandi ML.

Endocrine. 2018 Oct;62(1):234-241. doi: 10.1007/s12020-018-1668-3.

PMID:
30032405
46.

Phosphate wasting disorders in adults.

Marcucci G, Masi L, Ferrarì S, Haffner D, Javaid MK, Kamenický P, Reginster JY, Rizzoli R, Brandi ML.

Osteoporos Int. 2018 Nov;29(11):2369-2387. doi: 10.1007/s00198-018-4618-2. Epub 2018 Jul 16. Review.

PMID:
30014155
47.

Understanding osteoporotic pain and its pharmacological treatment: supplementary presentation.

Vellucci R, Terenzi R, Kanis JA, Kress HG, Mediati RD, Reginster JY, Rizzoli R, Brandi ML.

Osteoporos Int. 2018 Sep;29(9):2153-2154. doi: 10.1007/s00198-018-4536-3. Epub 2018 Jul 10.

PMID:
29992509
48.

Guidelines for the management of osteoporosis and fragility fractures.

Nuti R, Brandi ML, Checchia G, Di Munno O, Dominguez L, Falaschi P, Fiore CE, Iolascon G, Maggi S, Michieli R, Migliaccio S, Minisola S, Rossini M, Sessa G, Tarantino U, Toselli A, Isaia GC.

Intern Emerg Med. 2019 Jan;14(1):85-102. doi: 10.1007/s11739-018-1874-2. Epub 2018 Jun 13.

49.

Understanding osteoporotic pain and its pharmacological treatment.

Vellucci R, Terenzi R, Kanis JA, Kress HG, Mediati RD, Reginster JY, Rizzoli R, Brandi ML.

Osteoporos Int. 2018 Jul;29(7):1477-1491. doi: 10.1007/s00198-018-4476-y. Epub 2018 Apr 4. Review.

PMID:
29619540
50.

Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Saponaro F, Cetani F, Repaci A, Pagotto U, Cipriani C, Pepe J, Minisola S, Cipri C, Vescini F, Scillitani A, Salcuni A, Palmieri S, Eller-Vainicher C, Chiodini I, Madeo B, Kara E, Castellano E, Borretta G, Gianotti L, Romanelli F, Camozzi V, Faggiano A, Corbetta S, Cianferotti L, Brandi ML, De Feo ML, Palermo A, Vezzoli G, Maino F, Scalese M, Marcocci C.

J Endocrinol Invest. 2018 Nov;41(11):1339-1348. doi: 10.1007/s40618-018-0879-z. Epub 2018 Apr 3.

PMID:
29616419

Supplemental Content

Loading ...
Support Center